FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the pharmaceutical industry and represents a composition for improving the general state accompanying hypoalbuminemia, wherein the composition contains leucine and isoleucine and is free from valine.
EFFECT: invention provides extending the range of products improving the general state accompanying hypoalbuminemia.
5 cl, 4 tbl, 1 dwg
Authors
Dates
2015-08-10—Published
2011-03-31—Filed